Search Results - Inge Lues

  • Showing 1 - 6 results of 6
Refine Results
List   Grid  
  1. 1

    Passive Aβ Immunotherapy: Current Achievements and Future Perspectives by Stephan Schilling, Jens-Ulrich Rahfeld, Inge Lues, Cynthia A. Lemere

    Published 2018-05-01
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2

    Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients by Claire Bridel, Torsten Hoffmann, Antje Meyer, Sisi Durieux, Marleen A. Koel-Simmelink, Matthias Orth, Philip Scheltens, Inge Lues, Charlotte E. Teunissen

    Published 2017-06-01
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3

    Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer’s disease with reduced complement activation by Thore Hettmann, Stephen D. Gillies, Martin Kleinschmidt, Anke Piechotta, Koki Makioka, Cynthia A. Lemere, Stephan Schilling, Jens-Ulrich Rahfeld, Inge Lues

    Published 2020-02-01
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4

    Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation by Maike Hartlage-Rübsamen, Alexandra Bluhm, Anke Piechotta, Miriam Linnert, Jens-Ulrich Rahfeld, Hans-Ulrich Demuth, Inge Lues, Peer-Hendrik Kuhn, Stefan F. Lichtenthaler, Steffen Roßner, Corinna Höfling

    Published 2018-04-01
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5

    Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study by Philip Scheltens, Merja Hallikainen, Timo Grimmer, Thomas Duning, Alida A Gouw, Charlotte E Teunissen, Alle Meije Wink, Paul Maruff, John Harrison, Caroline M van Baal, Suzanne Bruins, Inge Lues, Niels D Prins

    Published 2018-10-01
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6

    Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice by Helen Crehan, Bin Liu, Martin Kleinschmidt, Jens-Ulrich Rahfeld, Kevin X. Le, Barbara J. Caldarone, Jeffrey L. Frost, Thore Hettmann, Birgit Hutter-Paier, Brian O’Nuallain, Mi-Ae Park, Marcelo F. DiCarli, Inge Lues, Stephan Schilling, Cynthia A. Lemere

    Published 2020-01-01
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: